Previous close | 1.8700 |
Open | 1.9500 |
Bid | 1.8500 x 1100 |
Ask | 1.9000 x 3200 |
Day's range | 1.8500 - 2.0000 |
52-week range | 1.5050 - 7.5300 |
Volume | |
Avg. volume | 1,109,848 |
Market cap | 124.257M |
Beta (5Y monthly) | 0.76 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.4090 |
Earnings date | 03 Aug 2022 - 08 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 11.14 |
Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Spare a thought for those who held...
With me today are Dr. Sean McCarthy, CytomX's chief executive offices and chairman; Amy Peterson, president and chief operating officer; and Carlos Campoy, chief financial officer. Please note that during today's call, we will be making forward-looking statements.
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -5.71% and 21.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?